Krystal Biotech, Inc. (KRYS)
295.21
+3.28
(+1.12%)
USD |
NASDAQ |
Jan 14, 14:52
Krystal Biotech Price: 295.21 for Jan. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| DexCom, Inc. | 69.04 |
| BioLife Solutions, Inc. | 24.19 |
| Alnylam Pharmaceuticals, Inc. | 364.99 |
| Catalyst Pharmaceuticals, Inc. | 22.96 |
| Amicus Therapeutics, Inc. | 14.36 |
Price Related Metrics
| PE Ratio | 44.28 |
| PS Ratio | 23.60 |
| PEG Ratio | 0.1598 |
| Price to Book Value | 7.523 |
| Price to Free Cash Flow | 53.19 |
| Earnings Yield | 2.26% |
| Market Cap | 8.560B |
| PEGY Ratio | 0.1598 |
| Operating PE Ratio | 55.66 |
| Normalized PE Ratio | 44.28 |